Literature DB >> 11868161

Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by splice-junction mutations in RLBP1.

Erica R Eichers1, Jane S Green, David W Stockton, Christopher S Jackman, James Whelan, J Arch McNamara, Gordon J Johnson, James R Lupski, Nicholas Katsanis.   

Abstract

Some isolated populations exhibit an increased prevalence of rare recessive diseases. The island of Newfoundland is a characteristic geographic isolate, settled by a small number of families primarily during the late 1700s and early 1800s. During our studies of this population, we identified a group of families exhibiting a retinal dystrophy reminiscent of retinitis punctata albescens but with a substantially lower age at onset and more-rapid and distinctive progression, a disorder that we termed "Newfoundland rod-cone dystrophy" (NFRCD). The size of one of these families was sufficient to allow us to perform a genomewide screen to map the NFRCD locus. We detected significant linkage to markers on the long arm of chromosome 15, in a region encompassing RLBP1, the gene encoding the cellular retinaldehyde-binding protein. Previously, mutations in RLBP1 have been associated with other retinal dystrophies, leading us to hypothesize that RLBP1 mutations might also cause NFRCD. To test this hypothesis, we sequenced all coding exons and splice junctions of RLBP1. We detected two sequence alterations, each of which is likely to be pathogenic, since each segregates with the disease and is predicted to interfere with mRNA splicing. In contrast to some previously reported RLBP1 mutations, which yield a protein that may retain some residual activity, each NFRCD mutation is likely to give rise to a null allele. This difference may account for the severe phenotype in these families and exemplifies the molecular continuum that underlies clinically distinct but genetically related entities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11868161      PMCID: PMC379124          DOI: 10.1086/339688

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

Review 1.  Nonsense-mediated mRNA decay in health and disease.

Authors:  P A Frischmeyer; H C Dietz
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

Review 2.  mRNA quality control: Marking the message for life or death.

Authors:  J Lykke-Andersen
Journal:  Curr Biol       Date:  2001-02-06       Impact factor: 10.834

3.  Electrophysiological findings in two young patients with Bothnia dystrophy and a mutation in the RLBP1 gene.

Authors:  L Gränse; M Abrahamson; V Ponjavic; S Andréasson
Journal:  Ophthalmic Genet       Date:  2001-06       Impact factor: 1.803

4.  Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation.

Authors:  J C Saari; M Nawrot; B N Kennedy; G G Garwin; J B Hurley; J Huang; D E Possin; J W Crabb
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

5.  Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees.

Authors:  N Katsanis; R A Lewis; D W Stockton; P M Mai; L Baird; P L Beales; M Leppert; J R Lupski
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome.

Authors:  N Katsanis; P L Beales; M O Woods; R A Lewis; J S Green; P S Parfrey; S J Ansley; W S Davidson; J R Lupski
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder.

Authors:  N Katsanis; S J Ansley; J L Badano; E R Eichers; R A Lewis; B E Hoskins; P J Scambler; W S Davidson; P L Beales; J R Lupski
Journal:  Science       Date:  2001-09-21       Impact factor: 47.728

8.  Fundus albipunctatus and retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1.

Authors:  N Katsanis; N F Shroyer; R A Lewis; J C Cavender; A A Al-Rajhi; M Jabak; J R Lupski
Journal:  Clin Genet       Date:  2001-06       Impact factor: 4.438

9.  Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci.

Authors:  P L Beales; N Katsanis; R A Lewis; S J Ansley; N Elcioglu; J Raza; M O Woods; J S Green; P S Parfrey; W S Davidson; J R Lupski
Journal:  Am J Hum Genet       Date:  2001-02-01       Impact factor: 11.025

10.  Ocular phenotype of bothnia dystrophy, an autosomal recessive retinitis pigmentosa associated with an R234W mutation in the RLBP1 gene.

Authors:  M S Burstedt; K Forsman-Semb; I Golovleva; T Janunger; L Wachtmeister; O Sandgren
Journal:  Arch Ophthalmol       Date:  2001-02
View more
  27 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Fundus autofluorescence, optical coherence tomography, and electroretinogram findings in choroidal sclerosis.

Authors:  John C Hwang; David Y Kim; Chai Lin Chou; Stephen H Tsang
Journal:  Retina       Date:  2010 Jul-Aug       Impact factor: 4.256

3.  Linkage disequilibrium mapping in the Newfoundland population: a re-evaluation of the refinement of the Bardet-Biedl syndrome 1 critical interval.

Authors:  Yanli Fan; Jane S Green; Alison J Ross; Philip L Beales; Patrick S Parfrey; William S Davidson
Journal:  Hum Genet       Date:  2004-10-23       Impact factor: 4.132

4.  CRALBP supports the mammalian retinal visual cycle and cone vision.

Authors:  Yunlu Xue; Susan Q Shen; Jonathan Jui; Alan C Rupp; Leah C Byrne; Samer Hattar; John G Flannery; Joseph C Corbo; Vladimir J Kefalov
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

Review 5.  Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Authors:  Muhammad Umar Ali; Muhammad Saif Ur Rahman; Jiang Cao; Ping Xi Yuan
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

6.  Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type.

Authors:  Marie S I Burstedt; Eva Mönestam
Journal:  Clin Ophthalmol       Date:  2010-03-24

7.  Bothnia dystrophy is caused by domino-like rearrangements in cellular retinaldehyde-binding protein mutant R234W.

Authors:  Xiaoqin He; Joel Lobsiger; Achim Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

Review 8.  Retinal dystrophies, genomic applications in diagnosis and prospects for therapy.

Authors:  Benjamin M Nash; Dale C Wright; John R Grigg; Bruce Bennetts; Robyn V Jamieson
Journal:  Transl Pediatr       Date:  2015-04

9.  Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosa.

Authors:  K T Oh; D M Oh; R G Weleber; E M Stone; A Parikh; J White; K A Deboer-Shields; L Streb; C Vallar
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 10.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.